본문으로 건너뛰기
← 뒤로

Diagnostic and treatment challenges associated with the atypical presentation of ALK-positive anaplastic large cell lymphoma in a Jehovah's Witness patient.

2/5 보강
BMJ case reports 📖 저널 OA 40.9% 2021: 14/14 OA 2022: 17/17 OA 2023: 7/7 OA 2024: 2/12 OA 2025: 7/73 OA 2026: 4/71 OA 2021~2026 2026 Vol.19(3) Lymphoma Diagnosis and Treatment
TL;DR This case underscores the importance of a broad differential diagnosis, judicious use of advanced diagnostics and individualised treatment planning, particularly in rare and aggressive lymphoproliferative disorders, particularly in rare and aggressive lymphoproliferative disorders.
Retraction 확인
출처
PubMed DOI OpenAlex Semantic 마지막 보강 2026-05-02
OpenAlex 토픽 · Lymphoma Diagnosis and Treatment Viral-associated cancers and disorders Chronic Lymphocytic Leukemia Research

Pramanik D, Mendes Correa BH, Jheasha AAA, Peysin C

📝 환자 설명용 한 줄

This case underscores the importance of a broad differential diagnosis, judicious use of advanced diagnostics and individualised treatment planning, particularly in rare and aggressive lymphoprolifera

이 논문을 인용하기

↓ .bib ↓ .ris
APA Debolina Pramanik, Bernardo Henrique Mendes Correa, et al. (2026). Diagnostic and treatment challenges associated with the atypical presentation of ALK-positive anaplastic large cell lymphoma in a Jehovah's Witness patient.. BMJ case reports, 19(3). https://doi.org/10.1136/bcr-2025-267859
MLA Debolina Pramanik, et al.. "Diagnostic and treatment challenges associated with the atypical presentation of ALK-positive anaplastic large cell lymphoma in a Jehovah's Witness patient.." BMJ case reports, vol. 19, no. 3, 2026.
PMID 41871898 ↗

Abstract

A male in his 50s presented with profound leucocytosis, systemic symptoms and marked hepatosplenomegaly. Initial workup with peripheral blood flow cytometry suggested T-cell prolymphocytic leukaemia as the most likely diagnosis. However, bone marrow biopsy with comprehensive immunogenetic testing ultimately identified anaplastic lymphoma kinase-positive anaplastic large cell lymphoma in its leukemic phase. The treatment course was with targeted agents with less immunosuppressive risk, after taking into consideration that he was a Jehovah's Witness, who would not be able to receive blood products. Despite a transient response, the disease progressed rapidly. This case underscores the importance of a broad differential diagnosis, judicious use of advanced diagnostics and individualised treatment planning, particularly in rare and aggressive lymphoproliferative disorders.

🏷️ 키워드 / MeSH 📖 같은 키워드 OA만

🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반